Illumina, Inc.

Illumina, Inc. is a global leader in DNA sequencing and array-based genomic analysis, providing comprehensive solutions for research, clinical diagnostics, and precision health applications. The company manufactures next-generation sequencing (NGS) platforms ranging from benchtop to production-scale instruments, microarray systems for genetic analysis, and library preparation kits optimized for diverse DNA and RNA workflows. Illumina's product portfolio includes the TruPath Genome solution, Single Cell 3' RNA Prep kits, and associated bioinformatics software for data analysis and insights. The company serves academic research institutions, clinical laboratories, pharmaceutical companies, and healthcare providers globally, enabling applications in cancer research, genetic disease testing, infectious disease surveillance, reproductive health, and precision medicine. Illumina offers 24/7 technical support, comprehensive documentation, training resources, and multiple financing options for instrument acquisition. The company maintains regulatory compliance with FDA clearances and international standards, and provides worldwide distribution through channel partners and direct sales. Corporate headquarters located in San Diego, CA with regional offices and support centers across North America, Europe, Asia-Pacific, and other global markets.